191 postdoctoral-position-in-polymer-molecular-simulation Postdoctoral positions at University of Oxford
Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
We are seeking to appoint a talented and ambitious Postdoctoral Research Assistant to join the Bacterial Pathogenesis and Innate Immune Signalling group, based at the Sir William Dunn School
-
Location: South Parks Road, Oxford We are seeking to appoint a talented and ambitious Postdoctoral Research Assistant to join the Bacterial Pathogenesis and Innate Immune Signalling group, based
-
About the role Applications are invited for the position of Postdoctoral Research Associate in the Synthesis of Porphyrin Arrays & Molecular Compasses to work under the supervision of Professor
-
The University of Oxford is seeking a Postdoctoral Researcher to join our laboratory team in the Radcliffe Department of Medicine (RDM) Division of Cardiovascular Medicine. RDM-Cardiovascular
-
Multiphysics software (COMSOL and/or Abaqus), python/matlab coding and Molecular Dynamics Simulator (LAMMPs). 4. Publications in mechanical metamaterials, soft robotics, or related area in peer-reviewed
-
About the role Applications are invited for a Postdoctoral Research Associate in Polymerization Catalysis to work with Professor Charlotte Williams for a period of up to 5 months. The post is funded
-
have recently highlighted the importance of the FAT1 gene during carcinogenesis (Lu et al, Nature Cell Biology 2025; Lu and Kanu, Nature Cell Biology 2025). We strive to understand the molecular
-
The Department of Sociology is seeking a Postdoctoral Researcher in Demography to work broadly in the area of fertility and reproductive behaviour. Applicants with interests in both formal and
-
the first instance Hours: Full Time (37.5 hours per week) About the role We are seeking to appoint a talented Postdoctoral Research Associate to join the group of Prof Ben Berks to study the bacterial Type 9
-
, Surveillance & Exploration). This innovative initiative, established in 2024, is a collaboration between the University of Oxford and GlaxoSmithKline (GSK) aimed at identifying molecular vulnerabilities in